Immuno-oncology on Clubhouse
758
Members
Updated: Jun 1, 2024
Description
Here we discuss the latest advancements in the fields of tumor immunology and cancer immunotherapy.
Last 30 Records
| Day | Members | Gain | % Gain |
|---|---|---|---|
| June 01, 2024 | 758 | +3 | +0.4% |
| March 08, 2024 | 755 | +2 | +0.3% |
| January 18, 2024 | 753 | +3 | +0.4% |
| December 04, 2023 | 750 | +1 | +0.2% |
| October 29, 2023 | 749 | +1 | +0.2% |
| September 28, 2023 | 748 | +2 | +0.3% |
| August 30, 2023 | 746 | -1 | -0.2% |
| July 27, 2023 | 747 | 0 | 0.0% |
| July 01, 2023 | 747 | -7 | -1.0% |
| April 05, 2023 | 754 | 0 | 0.0% |
| March 11, 2023 | 754 | +3 | +0.4% |
| February 02, 2023 | 751 | +1 | +0.2% |
| January 30, 2023 | 750 | +2 | +0.3% |
| January 26, 2023 | 748 | +1 | +0.2% |
| January 22, 2023 | 747 | -1 | -0.2% |
| January 07, 2023 | 748 | +1 | +0.2% |
| January 03, 2023 | 747 | +1 | +0.2% |
| November 29, 2022 | 746 | +1 | +0.2% |
| November 03, 2022 | 745 | +3 | +0.5% |
| October 27, 2022 | 742 | -1 | -0.2% |
| October 14, 2022 | 743 | +2 | +0.3% |
| September 29, 2022 | 741 | -2 | -0.3% |
| September 16, 2022 | 743 | +2 | +0.3% |
| September 10, 2022 | 741 | +1 | +0.2% |
| August 31, 2022 | 740 | +1 | +0.2% |
| August 25, 2022 | 739 | +3 | +0.5% |
| August 18, 2022 | 736 | -1 | -0.2% |
| August 12, 2022 | 737 | +4 | +0.6% |
| August 05, 2022 | 733 | +2 | +0.3% |
| July 30, 2022 | 731 | +1 | +0.2% |
